Hang Seng Innovation Drug ETF: On February 13, the margin buy-in was 9.2963 million yuan, and the margin and securities lending balance was 126 million yuan.

robot
Abstract generation in progress

Securities Star News, February 13 — Hang Seng Innovation Drug ETF (520500) had a margin buy-in of 9.2963 million yuan, a margin repayment of 13.2123 million yuan, resulting in a net margin sell of 3.9161 million yuan. The margin balance stands at 126 million yuan.

There were no securities lending transactions on this day.

The total margin and securities lending balance is 126 million yuan, down 3.02% from yesterday.

Quick Fact

Margin Trading and Securities Lending: The margin balance refers to the difference between the amount borrowed to buy stocks and the amount repaid. If the margin balance increases, it indicates investors are more bullish, and the market is popular, signaling a strong market; conversely, a decrease suggests a weak market. The securities lending balance is the difference between the amount of securities sold and repaid daily. An increase in securities lending balance indicates a seller’s market; a decrease suggests a buyer’s market.

The above content is compiled from public information by Securities Star, generated by AI algorithms (Wang Xin Suan Bei 310104345710301240019), and does not constitute investment advice.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)